東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Sustained Release of Growth Factors ...

Ramos Ferrer, Pablo.

FindBook

Google Book

Amazon

博客來

Sustained Release of Growth Factors From Hyaluronic Acid Hydrogels and Polyethylene-Glycol Microparticles for Axonal Growth.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Sustained Release of Growth Factors From Hyaluronic Acid Hydrogels and Polyethylene-Glycol Microparticles for Axonal Growth./
作者:	Ramos Ferrer, Pablo.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2023,
面頁冊數:	136 p.
附註:	Source: Dissertations Abstracts International, Volume: 85-07, Section: B.
Contained By:	Dissertations Abstracts International85-07B.
標題:	Chemical engineering. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30528714
ISBN:	9798381406412

Sustained Release of Growth Factors From Hyaluronic Acid Hydrogels and Polyethylene-Glycol Microparticles for Axonal Growth.
Ramos Ferrer, Pablo.

Sustained Release of Growth Factors From Hyaluronic Acid Hydrogels and Polyethylene-Glycol Microparticles for Axonal Growth. - Ann Arbor : ProQuest Dissertations & Theses, 2023 - 136 p.

Source: Dissertations Abstracts International, Volume: 85-07, Section: B.

Thesis (Ph.D.)--University of Washington, 2023.

The central nervous system, unlike other tissues, lacks the ability to spontaneously regenerate. During spinal cord injury, the disruption of axonal pathways is one of the main causes of functional loss. Neurotrophin-3 (NT-3) and insulin-like growth factor-1 (IGF-1) are two growth factors that have been shown to improve axonal growth and functional recovery in several studies, but there is a lack of effective delivery methods capable of maintaining their biological activity. In this work, we explored the feasibility of using injectable hyaluronic acid (HA) hydrogels and polyethylene glycol-diacrylate (PEG-DA) microparticles as platforms for sustained delivery of bioactive NT-3 and IGF-1, respectively. HA hydrogels were successfully synthesized using a polyethylene-glycol (PEG) dimaleimide crosslinker and characterized chemically and mechanically. The stiffness of the hydrogels was tuned to match that of central nervous tissue. Similarly, PEG-DA MPs were fabricated with acrylic acid as a comonomer and characterized. In the case of HA and NT-3, the drug release was measured, and the delivery mechanism was found to be controlled by electrostatic interactions between the negatively charged HA and the positively charged NT-3. IGF-1 showed a similar interaction when loaded onto and released from the PEG-DA MPs, displaying higher binding when the concentration of acrylic acid present was increased. The presence of affinity binding between the negatively charged polymeric systems and cationic proteins enabled control over the loading and release of the growth factors. The biological activity of the released NT-3 and IGF-1 was confirmed using a dorsal root ganglion assay. The concentration of both growth factors in the media was correlated to the axonal growth of primary sensory neurons, as well as that of stem cell-derived motoneurons and interneurons to more closely match the type of cells that are present in the spinal cord. A synergistic effect on neurite outgrowth was found for the combination of NT-3 and IGF-1, confirmed via phosphorylation of ERK1/2 in the shared downstream signaling pathway of both growth factors. The hydrogel provided an attractive platform for tissue sparing and neural fiber sprouting when neurons were cultured within the scaffolds and were shown to extend neurite processes. The MPs showed high cytocompatibility, suggesting their potential to be translated from in vitro to in vivo. This dual delivery system presents a promising alternative to current treatments for SCI but further work is needed to confirm their effect on in vivo axonal growth and functional recovery.

ISBN: 9798381406412Subjects--Topical Terms:

560457
Chemical engineering.
Subjects--Index Terms:

Biomaterials

Sustained Release of Growth Factors From Hyaluronic Acid Hydrogels and Polyethylene-Glycol Microparticles for Axonal Growth.
LDR:03838nmm a2200385 4500 001 2399912
005 20240916070017.5
006 m o d
007 cr#unu||||||||
008 251215s2023 ||||||||||||||||| ||eng d
020 $a 9798381406412
035 $a (MiAaPQ)AAI30528714
035 $a AAI30528714
040 $a MiAaPQ $c MiAaPQ
100 1 $a Ramos Ferrer, Pablo. $3 3769889
245 1 0 $a Sustained Release of Growth Factors From Hyaluronic Acid Hydrogels and Polyethylene-Glycol Microparticles for Axonal Growth.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2023
300 $a 136 p.
500 $a Source: Dissertations Abstracts International, Volume: 85-07, Section: B.
500 $a Advisor: Sakiyama-Elbert, Shelly.
502 $a Thesis (Ph.D.)--University of Washington, 2023.
520 $a The central nervous system, unlike other tissues, lacks the ability to spontaneously regenerate. During spinal cord injury, the disruption of axonal pathways is one of the main causes of functional loss. Neurotrophin-3 (NT-3) and insulin-like growth factor-1 (IGF-1) are two growth factors that have been shown to improve axonal growth and functional recovery in several studies, but there is a lack of effective delivery methods capable of maintaining their biological activity. In this work, we explored the feasibility of using injectable hyaluronic acid (HA) hydrogels and polyethylene glycol-diacrylate (PEG-DA) microparticles as platforms for sustained delivery of bioactive NT-3 and IGF-1, respectively. HA hydrogels were successfully synthesized using a polyethylene-glycol (PEG) dimaleimide crosslinker and characterized chemically and mechanically. The stiffness of the hydrogels was tuned to match that of central nervous tissue. Similarly, PEG-DA MPs were fabricated with acrylic acid as a comonomer and characterized. In the case of HA and NT-3, the drug release was measured, and the delivery mechanism was found to be controlled by electrostatic interactions between the negatively charged HA and the positively charged NT-3. IGF-1 showed a similar interaction when loaded onto and released from the PEG-DA MPs, displaying higher binding when the concentration of acrylic acid present was increased. The presence of affinity binding between the negatively charged polymeric systems and cationic proteins enabled control over the loading and release of the growth factors. The biological activity of the released NT-3 and IGF-1 was confirmed using a dorsal root ganglion assay. The concentration of both growth factors in the media was correlated to the axonal growth of primary sensory neurons, as well as that of stem cell-derived motoneurons and interneurons to more closely match the type of cells that are present in the spinal cord. A synergistic effect on neurite outgrowth was found for the combination of NT-3 and IGF-1, confirmed via phosphorylation of ERK1/2 in the shared downstream signaling pathway of both growth factors. The hydrogel provided an attractive platform for tissue sparing and neural fiber sprouting when neurons were cultured within the scaffolds and were shown to extend neurite processes. The MPs showed high cytocompatibility, suggesting their potential to be translated from in vitro to in vivo. This dual delivery system presents a promising alternative to current treatments for SCI but further work is needed to confirm their effect on in vivo axonal growth and functional recovery.
590 $a School code: 0250.
650 4 $a Chemical engineering. $3 560457
650 4 $a Bioengineering. $3 657580
650 4 $a Neurosciences. $3 588700
653 $a Biomaterials
653 $a Drug delivery
653 $a Hyaluronic acid
653 $a Neurotrophin-3
653 $a Spinal cord injury
690 $a 0542
690 $a 0202
690 $a 0317
710 2 $a University of Washington. $b Chemical Engineering. $3 3178392
773 0 $t Dissertations Abstracts International $g 85-07B.
790 $a 0250
791 $a Ph.D.
792 $a 2023
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30528714